Health
Two doses required: AstraZeneca and Pfizer protect against Indian variant – The New Daily
The Pfizer and AstraZeneca vaccines are “highly effective” against symptomatic disease from the so-called Indian variant.
The Pfizer and AstraZeneca vaccines are “highly effective” against symptomatic disease from the so-called Indian variant coronavirus but only after two doses, a study has found.
Both vaccines are 33 per cent effective against the Indian variant three weeks after the first dose.
But following a second dose, protection against the B.1.617.2 Indian variant improved dramatically.
The Pfizer vaccine was found to be 88 per cent effective at stopping symptomatic disease from the Indian variant two weeks…
-
Noosa News18 hours agoPill checking to resume in Queensland months after government axed funding
-
Business21 hours agoWhy Austal, Boss Energy, Harvey Norman, and NextDC shares are charging higher today
-
Business22 hours agoASX shares are expensive. Here’s why you should be buying anyway
-
Business21 hours agoBrokers name 3 ASX shares to buy today 29 August 2025